The structural, functional and sheer mechanistic complexity of the neurotransmitter transporters (NTs) remains a significant challenge that we must continue to address because these cell components are responsible, as a class - the Neurotransmitter : Sodium Symporter (NSS) - and individually (DAT, SERT, NET) for major aspects of neuronal function in the brain. These membrane proteins play essential roles in cell signaling and, not surprisingly, are primary targets for medications (e.g., the antidepressants) as well as for abused drugs including the psychostimulants cocaine and amphetamine. The organization of the PPG and its Research Plan, in the 3 individual Projects and the 2 Cores, recognizes the rapid and abundant new developments in the field and new opportunities to understand the mechanisms of the NTs in the physiological processes underlying neurotransmission in general, and their involvement in drug addiction and abuse in particular. The long-term goals are to understand how the accumulation and efflux of neurotransmitters (e.g., dopamine) are regulated by post-translational modification of the NTs (DAT), by their association with other proteins, and by their localization to specific membrane micro-domains. Mechanistic details are sought to understand the molecular and cellular processes governing the activity and availability of the NTs, such as DAT, in the presynaptic membrane, and how these processes are altered in diseased states involving signaling dysfunction. With appreciation for the multidisciplinary, multiscale strategies required to achieve such goals, this renewal application builds upon the collaborative acumen and synergies established in the PPG consortium, and widens the focus to include elucidation of functional mechanisms in large membrane assemblies (Project 1), whole cells, tissues, and even whole animals (Projects 2&3 and Core B). To address these mechanisms in DAT and SERT, our research plan leverages as well new methodology, major equipment and expertise in many cognate areas, through extensive collaborations that the participating labs have established to create a multidisciplinary team even larger than the PPG, which that enhances and widens the power and scope of the innovative research proposed in this application.

Public Health Relevance

The dopamine transporter is responsible for the rewarding properties and abuse potential of cocaine, amphetamine, and related psychostimulants. The related transporters for serotonin and norepinephrine are targets for antidepressant medications and secondary targets for psychostimulants. We strive to understand how these transporters are regulated in health and in disease. OVERALL PROJECT

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
5P01DA012408-14
Application #
8435538
Study Section
Special Emphasis Panel (ZRG1-MDCN-G (51))
Program Officer
Hillery, Paul
Project Start
1999-07-09
Project End
2016-02-29
Budget Start
2013-03-01
Budget End
2014-02-28
Support Year
14
Fiscal Year
2013
Total Cost
$1,076,103
Indirect Cost
$160,798
Name
Weill Medical College of Cornell University
Department
Physiology
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Billesbølle, Christian B; Mortensen, Jonas S; Sohail, Azmat et al. (2016) Transition metal ion FRET uncovers K(+) regulation of a neurotransmitter/sodium symporter. Nat Commun 7:12755
Vuorenpää, Anne; Jørgensen, Trine N; Newman, Amy H et al. (2016) Differential Internalization Rates and Postendocytic Sorting of the Norepinephrine and Dopamine Transporters Are Controlled by Structural Elements in the N Termini. J Biol Chem 291:5634-51
Khelashvili, George; Schmidt, Solveig Gaarde; Shi, Lei et al. (2016) Conformational Dynamics on the Extracellular Side of LeuT Controlled by Na+ and K+ Ions and the Protonation State of Glu290. J Biol Chem 291:19786-99
Freyberg, Zachary; Sonders, Mark S; Aguilar, Jenny I et al. (2016) Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain. Nat Commun 7:10652
Stolzenberg, Sebastian; Michino, Mayako; LeVine, Michael V et al. (2016) Computational approaches to detect allosteric pathways in transmembrane molecular machines. Biochim Biophys Acta 1858:1652-62
Zhao, Yiming; Fay, François; Hak, Sjoerd et al. (2016) Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy. Nat Commun 7:11221
Apuschkin, Mia; Stilling, Sara; Rahbek-Clemmensen, Troels et al. (2015) A novel dopamine transporter transgenic mouse line for identification and purification of midbrain dopaminergic neurons reveals midbrain heterogeneity. Eur J Neurosci 42:2438-54
Billesbølle, Christian B; Krüger, Mie B; Shi, Lei et al. (2015) Substrate-induced unlocking of the inner gate determines the catalytic efficiency of a neurotransmitter:sodium symporter. J Biol Chem 290:26725-38
Khelashvili, George; Doktorova, Milka; Sahai, Michelle A et al. (2015) Computational modeling of the N-terminus of the human dopamine transporter and its interaction with PIP2 -containing membranes. Proteins 83:952-69
Stolzenberg, Sebastian; Quick, Matthias; Zhao, Chunfeng et al. (2015) Mechanism of the Association between Na+ Binding and Conformations at the Intracellular Gate in Neurotransmitter:Sodium Symporters. J Biol Chem 290:13992-4003

Showing the most recent 10 out of 130 publications